The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia

被引：0
|
作者：
Rachael L. DiSantostefano
Andrea K. Biddle
John P. Lavelle
机构：
[1] School of Public Health,Department of Health Policy and Administration
[2] University of North Carolina at Chapel Hill,Carolina Program in Healthcare and Aging Research
[3] Institute on Aging,Division of Urology
[4] University of North Carolina,undefined
[5] School of Medicine,undefined
[6] University of North Carolina,undefined
来源：
PharmacoEconomics | 2006年 / 24卷
关键词：
Benign Prostatic Hyperplasia; Lower Urinary Tract Symptom; Urinary Symptom; Watchful Waiting; Utility Weight;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：171 / 191
页数：20
相关论文
共 50 条
  • [1] Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway
    Johansen, Truls E. Bjerklund
    Istad, Jan Anders
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2007, 41 (02): : 124 - 131
  • [2] Experience of Long-Term Afala Treatment in Benign Prostatic Hyperplasia
    A. V. Gudkov
    Bulletin of Experimental Biology and Medicine, 2009, 148
  • [3] Experience of Long-Term Afala Treatment in Benign Prostatic Hyperplasia
    Gudkov, A. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 148 (02) : 308 - 311
  • [4] LONG-TERM EXPERIENCE WITH THE PROSTATIC SPIRAL FOR URINARY RETENTION DUE TO BENIGN PROSTATIC HYPERPLASIA
    GUAZZONI, G
    MONTORSI, F
    COLOMBO, R
    DIGIROLAMO, V
    DAPOZZO, L
    RIGATTI, P
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1991, 25 (01): : 21 - 24
  • [5] Long-term results of surgical techniques and procedures in men with benign prostatic hyperplasia
    Metcalfe C.
    Poon K.S.
    Current Urology Reports, 2011, 12 (4) : 265 - 273
  • [6] Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
    Chughtai, Bilal
    Rojanasarot, Sirikan
    Neeser, Kurt
    Gultyaev, Dmitry
    Amorosi, Stacey L.
    Shore, Neal D.
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2021, 8 (01): : 42 - 50
  • [7] Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia
    Chughtai, Bilal
    Elterman, Dean S.
    Lee, Richard
    Te, Alexis E.
    Kaplan, Steven A.
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (05) : 267 - 272
  • [8] Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore
    Chay, Junxing
    Tung, Joshua Yi Min
    Su, Rebecca Jade
    Aslim, Edwin Jonathan
    Wong, Callix
    Swan, Georgia
    Chua, Wei Jin
    Ho, Henry Sun Sien
    Finkelstein, Eric Andrew
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1269 - 1277
  • [9] Cost analysis of alpha blocker treatments for benign prostatic hyperplasia in Medicare beneficiaries
    Sidi, Yulia
    Duan, Yinghui
    Rhee, Taeho Greg
    Wu, Z. Helen
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2021, 17 (06) : 1119 - 1139
  • [10] Transurethral hyperthermia for benign prostatic hyperplasia: Long term results
    Petrovich, Z
    Pike, MC
    Boyd, SD
    Jozsef, G
    Astrahan, MA
    Baert, L
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1996, 12 (05) : 595 - 606
12345